Condensed Consolidated Statements of Cash Flows - USD ($) |
6 Months Ended | 12 Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||||||
| Loss before taxation | $ (1,161,471) | $ 872,075 | $ (4,862,470) | $ (9,257,598) | ||||||||||||||||
| Adjustments for: | ||||||||||||||||||||
| Amortization – right-of-use assets | 63,036 | 33,672 | 99,580 | |||||||||||||||||
| Depreciation – plant and equipment | 3,696 | 3,696 | 1,007 | |||||||||||||||||
| Impairment losses (reversed) recognized in respect of trade receivables | 10,018 | 10,840 | (400) | 5,032 | ||||||||||||||||
| Write-off of due from a related company | [1] | 81,347 | ||||||||||||||||||
| Bad debt written off | 21,522 | 14,752 | ||||||||||||||||||
| Finance costs | 243,537 | 279,516 | 552,651 | 220,460 | ||||||||||||||||
| Share option awards | 320,533 | 1,232,071 | 1,352,835 | 587,821 | ||||||||||||||||
| Share-based payments expenses on anti-dilution issuance of preferred shares | [2] | 369,648 | ||||||||||||||||||
| Net fair value loss of convertible loan notes | 274,000 | [3] | 126,000 | [3] | 374,000 | [4] | 19,000 | [4] | ||||||||||||
| Net fair value (gain) loss of preferred shares | (3,539,648) | [5] | (5,044,000) | [5] | (4,101,000) | [6] | 1,841,000 | [6] | ||||||||||||
| Operating cash flows before movements in working capital | (3,420,347) | (2,486,130) | (6,478,239) | (6,568,526) | ||||||||||||||||
| Trade receivables | 87,552 | 137,489 | 86,332 | (43,726) | ||||||||||||||||
| Other receivables, deposit, and prepayment | (210,466) | (90,946) | (210,936) | 132,684 | ||||||||||||||||
| Contract assets | (18,028) | (47,196) | (42,365) | 42,158 | ||||||||||||||||
| Due from a related company | (3,560) | (39,815) | (41,532) | |||||||||||||||||
| Trade and other payables | 589,091 | 682,003 | 841,155 | (131,331) | ||||||||||||||||
| Deferred revenue | 51,885 | (160,351) | (12,840) | 18,955 | ||||||||||||||||
| Net cash used in operating activities | (2,920,313) | (1,968,691) | (5,856,708) | (6,591,318) | ||||||||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||||||
| Proceeds from issuance of ordinary shares | 50 | |||||||||||||||||||
| Proceeds from issuance of convertible loan notes | 100,000 | 100,000 | 3,250,000 | |||||||||||||||||
| Advances from immediate holding company | 713,719 | 200,000 | 5,345,423 | 600,000 | ||||||||||||||||
| Loans from immediate holding company | 2,335,461 | 564,483 | 564,483 | 2,250,000 | ||||||||||||||||
| Loan from a related company | 1,000,000 | |||||||||||||||||||
| Repayment of lease liabilities | (104,715) | (37,065) | (109,754) | |||||||||||||||||
| Repayment of loans from immediate holding company | (1,150,000) | (600,000) | ||||||||||||||||||
| Net cash generated from financing activities | 2,944,515 | 827,418 | 4,750,152 | 6,500,000 | ||||||||||||||||
| NET DECREASE IN CASH AND CASH EQUIVALENTS | 24,202 | (1,141,273) | (1,106,556) | (91,318) | ||||||||||||||||
| Cash and cash equivalents at the beginning of the year | 76,620 | 1,183,176 | 1,183,176 | 1,274,494 | ||||||||||||||||
| CASH AND CASH EQUIVALENTS AT END OF YEAR | $ 100,822 | $ 41,903 | $ 76,620 | $ 1,183,176 | ||||||||||||||||
| ||||||||||||||||||||